RAPT has been granted a new patent
Jan 29, 2025, 11:39 PM
-6.03%
What does RAPT do
Rapt Therapeutics, based in South San Francisco, specializes in developing oral small molecule therapies for oncology and inflammatory diseases, with key candidates targeting CCR4. The company went public on October 31, 2019, and employs 126 people.
RAPT filed a patent for "crystalline forms of c-c chemokine receptor type 4 antagonist and uses thereof" on Wed, July 12, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.